RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
EpicentRx, Inc.
EpicentRx, Inc.
Canadian Cancer Trials Group
AIDS Malignancy Consortium
Dana-Farber Cancer Institute
NewVac LLC
University of California, San Francisco
AstraZeneca